1. Mayo clinic, the location of lenzilumab's study, has had phenomenal Covid results. 1% of their patients passed away vs 3% national average. The Mayo Clinic is a top notch facility but general good medical care isn't enough to explain such success. But a wunderdrug would explain it.
3. On March 5th, two South Korean companies that HGEN has partnered with both had their stocks rise which caused HGEN's stock to shoot from $15 to $22 in premarket trading. Insider information has many ways to leak. HGEN talking to our partners is one way. Just because investors are in the dark doesn't mean things aren't happening behind the scenes with manufacturing and commercialization.
4. The UK study coming out confirming that targeting GM-CSF is the way to treat Covid. This is history in the making.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.